Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three‐year follow‐up data of a single‐blind randomized controlled trial

Background Anti‐drug antibodies (ADA) are formed in patients treated with adalimumab (ADL). This might increase clearance of ADL, potentially causing a (secondary) non‐response. Combination therapy of ADL and methotrexate (MTX) reduces ADA levels and has a clinical benefit in rheumatologic diseases....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2023-09, Vol.37 (9), p.1815-1824
Hauptverfasser:	Huizen, Astrid M., Kraaij, Gayle E., Busard, Celine I., Ouwerkerk, Wouter, Reek, Juul M. P. A., Menting, Stef P., Prens, Errol P., Rispens, Theo, Vries, Annick, Jong, Elke M. G. J., Lambert, Jo, Doorn, Martijn B. A., Spuls, Phyllis I.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!